Piramal Critical Care on Wednesday said it has partnered with US-based pharmaceutical outsourcing facility Medivant Healthcare to address severe shortage of injectable drugs in hospitals across the United States...
GSK buys 10% of CureVac in vaccine tech deal
GSK is to buy a 10% stake in German biotech company CureVac for 130 million pounds ($163.67 million), the two companies said on Monday, in a deal that bets on new technologies already being used in potential COVID-19...
Spanish pharma Grifols buys plasma assets from Green Cross for $460 million
Spanish pharmaceutical company Grifols said on Monday it agreed to buy plasma assets in North America from South Korea’s Green Cross for $460 million. Grifols will buy a plasma fractionation plant in Canada and two...
Roche to pay Blueprint up to $1.7 billion in cancer drug deal
Swiss drugmaker Roche on Tuesday struck a deal worth up to $1.7 billion with Blueprint Medicines to develop and commercialise a new treatment for people with so-called RET-altered cancers whose mutations can drive...
Apax mulls sale of Neuraxpharm to lock in pharma sector premium: sources
Buyout group Apax is preparing the sale of German pharma group Neuraxpharm to try to lock in high valuations in the healthcare sector, fuelled by the coronavirus pandemic, sources familiar with the matter said. Apax has...
Johnson & Johnson’s Cilag to sell up to 11.8 million Idorsia shares
Johnson & Johnson’s Cilag Holding will offer up to approximately 11.8 million existing ordinary shares in Idorsia Ltd in an accelerated bookbuilding to commence on Wednesday, the transaction’s bookrunner said. The...
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: report
Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential COVID-19 vaccine, the Sunday Times reported. Clinical trials are due to start in...
KKR to acquire controlling stake in JB Chemicals
J.B. Chemicals products include in the areas of cardiac, gastrointestinal and anti-infective therapeutic across the branded formulations market. The company’s portfolio includes four flagship brands in India, Cilacar...
Dr Reddy’s partners Fujifilm to launch Avigan for Covid-19 treatment
Indian generic drug maker Dr Reddy’s Laboratories has partnered with the Japanese pharma giant Fujifilm Toyama Chemical and Global Response Aid (GRA) for development, manufacture and sale of antiviral drug Avigan...
Novozymes buys Irish probiotic maker PrecisionBiotics
Danish enzyme maker Novozymes NZYMB.CO will buy Ireland-based PrecisionBiotics in a $90 million deal, it said on Thursday, its second acquisition of a probiotics company in recent years as it seeks to grow its human...
Japan’s Sosei Group signs $377 million drug discovery deal with Abbvie
Japan’s Sosei Group Corp will collaborate with Abbvie Inc on drug discovery in a deal worth up to $377 million, the companies said on Thursday. Sosei shares climbed 10% in Tokyo trading, compared with a 1% slide in the...
Sanofi clinches $2 billion vaccines deal with Translate Bio
French drugmaker Sanofi has agreed a potential $2 billion vaccines deal with Translate Bio, expanding their collaboration in development of an inoculation against COVID-19 and sending the U.S. biotech company’s shares...
